The Patent Finder

Novalix

Also on record
Records under this name other than the patents Novalix holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Showing 1 to 6 of 6 · Back to Novalix

PatentTitleStatus Expires Confidence
US 9,309,241Naphthyridine Derivative Compounds
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,527,844Naphthyridine Derivative Compounds
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 9,757,364Naphthyridine derivative compounds
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 10,280,170SUBSTITUTED 4,5,6,7-Tetrahydro-PYRAZOLO[1,5-a]PYRAZINE DERIVATIVES AND 5,6,7,8-Tetrahydro-4H-PYRAZOLO[1,5-a][1,4]DIAZEPINE DERIVATIVES AS ROS1 INHIBITORS
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,526,316Quinoxaline and Pyridopyrazine Derivatives as PI3KB Inhibitors
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,130,751Quinoxaline and Pyridopyrazine Derivatives as PI3K-BETA Inhibitors
Lapsed on the fee record
Ended Sep 28, 2025 · High confidence
Lapsed on the fee recordEnded Sep 28, 2025High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited